The present invention provides compounds which are modulators of TNF- signaling and methods of use thereof for treating a patient having a TNF- mediated condition. The compounds can be represented by the following structural formulas: ##STR1##

 
Web www.patentalert.com

< Variants of traf2 which act as an inhibitor of tnf-alpha (tnf) signaling pathway

< Method of treating anemia by administering IL-1ra

> Compounds for the treatment of inflammatory disorders

> Amino terminal substance P compositions and methods for using the same
~ 00256